ICG-fluorescence Imaging for Intraoperative Breast Cancer Margins Evaluation: a Dose-timing Study

NCT06227338 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
250
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Jules Bordet Institute